lead position
Sponsored content
Sponsored by
Henry Goh & Co
Features list
-
Eric Marandett, Kerry Flynn and Dana Leigh Popkave outline key changes to the US law of written description that require new patent strategies, particularly for biotech and pharmaceutical companies
-
Amending patent applications in China can be difficult. Wang Guilian, a serving examiner of SIPO’s Patent Reexamination Board, offers some advice on how to get it right
-
For businesses, a .brand gTLD can look exciting on paper. New business opportunities and increased internet security appear enticing. But once they have committed to applying for a new gTLD, applicants must undertake a long consultation process and write their applications. They must provide detailed financial and technical information, and show to Icann that their .brand is a viable project.
-
In the light of recent cases in Europe, Catriona Smith and Colin Fowler argue that registered designs can be a useful tool for good designs that cannot be protected in other ways
-
The Court of Justice of the EU has banned patents on stem cells obtained from human embryos. Rob Fitt argues the reaction is exaggerated, and presents the options for the biotech industry
-
Brad Lyerla explains the approaches taken by US judges in claim construction hearings – and how understanding the distinction can help you to succeed in patent litigation
Local Insights